Search

everythinglearnresearchcommunity

for

Search:↓

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

N-acetylcysteine may help treat uterine and placental issues in PCOS.

PCOS affects multiple organs and requires combined treatment with lifestyle changes, metformin, and oral contraceptives.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Allergic cats with yeast overgrowth improved with antifungal treatment.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

Hair loss is influenced by genetics, diet, and lifestyle, but more research is needed on nutrition's role.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.